The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE President shares message of congratulations on Eid Al-Fitr
Dubai confirms success of interception operations on Friday
UAE responds to incoming missile, drone threats on Friday
UAE welcomes IMO council decision on Iranian attacks, Strait of Hormuz
